Reduction in infarct size, arrhythmias and chest pain by early intravenous beta blockade in suspected acute myocardial infarction.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Circulation

• Publication date

  1983-06-01

• Fields of study

  Medicine

• Identifiers
  PMID 6851037
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of cardioselective beta-blockade on heart function and chest pain in acute myocardial infarction.

  2009cited by this paper
• Early intravenous atenolol treatment in suspected acute myocardial infarction.

  2009cited by this paper
• Reduction of ventricular arrhythmias by early intravenous atenolol in suspected acute myocardial infarction.

  1983cited by this paper
• The Natural History of Coronary Heart Disease: Prognostic Factors After Recovery from Myocardial Infarction in 2789 Men The 5‐year Findings of the Coronary Drug Project prepared for the Coronary Drug Project Research Group bv

  1982cited by this paper
• Recurrent Myocardial Infarction: Clinical Predictors and Prognostic Implications

  1982cited by this paper
• Ischemic pain relief in patients with acute myocardial infarction by intravenous atenolol.

  1982cited by this paper
• The beta‐blocker heart attack trial.

  1982cited by this paper
• Early intravenous beta-blockade in myocardial infarction.

  1982cited by this paper
• Estimation of Acute Myocardial Infarct Size in Man by Serum CK‐MB Measurements

  1982cited by this paper
• A QRS scoring system for assessing left ventricular function after myocardial infarction.

  1982cited by this paper
• Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial.

  1981cited by this paper
• Variability of electrocardiographic and enzyme evolution of myocardial infarction in man.

  1981cited by this paper
• Limitation of myocardial infarct size in patients less than 66 years treated with alprenolol.

  1981cited by this paper
• Early intravenous atenolol treatment in suspected acute myocardial infarction. Preliminary report of a randomised trial.

  1980cited by this paper
• Predictors of late hospital death in acute myocardial infarction.

  1980cited by this paper
• Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction.

  1980cited by this paper
• Prophylaxis of ventricular fibrillation after acute experimental coronary occlusion by chronic beta-adrenoceptor blockade with atenolol.

  1979cited by this paper
• The Effect of Delay in Propranolol Administration on Reduction of Myocardial Infarct Size After Experimental Coronary Artery Occlusion in Dogs

  1979cited by this paper
• Value of electrocardiogram in predicting and estimating infarct size in man.

  1979cited by this paper
• Effect of beta-blockers on arrhythmias during six weeks after suspected myocardial infarction

  1979cited by this paper
• Enzymatic Indices of Myocardial Necrosis: Influence on Short- and Long-Term Prognosis After Myocardial Infarction

  1979cited by this paper
• Protective effect of propranolol in threatened myocardial infarction.

  1978cited by this paper
• Reduction of Enzyme Levels by Propranolol After Acute Myocardial Infarction

  1978cited by this paper
• beta-Adrenergic blockade in acute myocardial infarction.

  1978cited by this paper
• Approach to the estimation of myocardial infarct size by analysis of precordial S-T segment and R wave maps.

  1978cited by this paper
• Precordial electrocardiographic mapping. A technique to assess the efficacy of interventions designed to limit infarct size.

  1978cited by this paper
• The pharmacology of atenolol.

  1977cited by this paper
• The Relationship between Enzymatic and Histologic Estimates of the Extent of Myocardial Infarction in Conscious Dogs with Permanent Coronary Occlusion

  1977cited by this paper
• Solid angle theory and the electrocardiogram: physiologic and quantitative interpretations.

  1977cited by this paper
• Serial CPK determinations for evaluation of size and development of acute myocardial infarction.

  1976cited by this paper
• PLASMA PROPRANOLOL CONCENTRATION IN PATIENTS WITH ANGINA AND ACUTE MYOCARDIAL INFARCTION

  1976cited by this paper
• Clinical measurement of myocardial infarct size. Modification of a method for the estimation of total creatine phosphokinase release after myocardial infarction.

  1975cited by this paper
• Estimation of Infarct Size in Man and its Relation to Prognosis

  1972cited by this paper
• Effects of a beta-adrenergic receptor blocker in myocardial infarction treated for one year from onset.

  1972cited by this paper
• A controlled trial of propranolol in acute myocardial infarction.

  1967cited by this paper
• A controlled trial of propranolol in acute myocardial infarction.

  1966cited by this paper
• Absence of prophylactic effect of propranolol in myocardial infarction.

  1966cited by this paper

• Coupling Interval Ratio to Predict the Beta-Blocker Response Against Premature Ventricular Complexes

  2025cites this paper
• Impact of Adherence to Beta-Blockers in Patients With All-Comers ST-Segment Elevation Myocardial Infarction and According to Left Ventricular Ejection Fraction at Discharge: Results From the Real-World Registry FAST-STEMI

  2024cites this paper
• Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning

  2022cites this paper
• Short-term triggers, treatment optimisation and risk stratification

  2019cites this paper
• Development of myocardial infarction

  2018cites this paper
• β-Blockers in myocardial infarction and coronary artery disease with a preserved ejection fraction: recommendations, mechanisms, and concerns.

  2018cites this paper
• Morphine decreases ticagrelor concentrations but not its antiplatelet effects: a randomized trial in healthy volunteers

  2016cites this paper
• The Effect of Pain and Morphine Use on Complication Rates after Acute Myocardial Infarction

  2016cites this paper
• Beta-blockers for suspected or diagnosed acute myocardial infarction.

  2016cites this paper
• Editor’s Choice-Chest pain relief in patients with acute myocardial infarction

  2016cites this paper
• Chronic β1-adrenoceptor blockade impairs ischaemic tolerance and preconditioning in murine myocardium.

  2016cites this paper
• Early Intravenous Beta-Blockers in Patients With ST-Segment Elevation Myocardial Infarction Before Primary Percutaneous Coronary Intervention.

  2016cites this paper
• 9th Hatter Biannual Meeting: position document on ischaemia/reperfusion injury, conditioning and the ten commandments of cardioprotection

  2016cites this paper
• A 35-year journey to evidence-based medicine: a personal story.

  2015cites this paper
• Therapeutic efficacy of early intravenous atenolol for acute coronary syndrome:a meta-analysis

  2014cites this paper
• Rationale and design of a double-blind, multicenter, randomized, placebo-controlled clinical trial of early administration of intravenous β-blockers in patients with ST-elevation myocardial infarction before primary percutaneous coronary intervention: EARLY β-blocker administration before primary PC

  2014cites this paper
• Clinical outcomes with β-blockers for myocardial infarction: a meta-analysis of randomized trials.

  2014cites this paper
• Morphine Is Associated With a Delayed Activity of Oral Antiplatelet Agents in Patients With ST-Elevation Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

  2014cites this paper
• Protective and pathological roles of tissue factor in the heart

  2014cites this paper
• Intravenous Beta Blockers in Primary PCI: New Hope for an Old Therapy

  2013cites this paper
• Effect of Early Metoprolol on Infarct Size in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary PCI: The METOCARD-CNIC Trial

  2013cites this paper
• Intravenous β-blockers in primary percutaneous coronary intervention: new hope for an old therapy.

  2013cites this paper
• Current practice on the management of acute coronary syndrome in China.

  2013cites this paper
• Early intravenous beta-blockers in patients with acute coronary syndrome--a meta-analysis of randomized trials.

  2013cites this paper
• Effect of Early Metoprolol on Infarct Size in ST-Segment–Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention The Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) Trial

  2013cites this paper
• Strathprints Institutional Repository

  2013cites this paper
• Effect of Early Metoprolol on Infarct Size in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary PCI: The METOCARD-CNIC Trial

  2013cites this paper
• Effect of Early Metoprolol on Infarct Size in ST-Segment–Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: The Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) Trial

  2013cites this paper
• (METOCARD-CNIC) Trial of Metoprolol in Cardioprotection During an Acute Myocardial Infarction Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: The Effect Elevation Myocardial - Effect of Early Metoprolol on Infarct Size in ST-Segment

  2013cites this paper
• CRITICAL CARE THERAPEUTICS

  2013cites this paper
• The Potential for Added Benefits with β-Blockers and Calcium Antagonists in Treating Cardiovascular Disorders

  2012cites this paper
• An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials.

  2012cites this paper
• Myocardial Infarction and Protection

  2012cites this paper
• Guía de práctica clínica de la ESC para el manejo del síndrome coronario agudo en pacientes sin elevación persistente del segmento ST

  2012cites this paper
• Efecto cardioprotector del metropolol en la reperfusión coronaria: analisis del miocardio isquémico en riesgo mediante resonancia magnética cardiaca

  2012cites this paper
• [Modulation of the beta-adrenergic system during acute myocardial infarction: rationale for a new clinical trial].

  2011cites this paper
• ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

  2011cites this paper
• Lethal myocardial reperfusion injury: a necessary evil?

  2011cites this paper
• Cardiac conditioning: a review of evolving strategies to reduce ischaemia–reperfusion injury

  2010cites this paper
• A Review and Meta-Analysis of Studies on the Effect and Timing of β-Blocker Administration in Patients with ST-Segment Elevation Myocardial Infarction

  2010cites this paper
• CHAPTER 14 – Medical Management of Unstable Angina and Non–ST Segment Elevation Myocardial Infarction

  2010cites this paper
• Does the early administration of beta-blockers improve the in-hospital mortality rate of patients admitted with acute coronary syndrome?

  2010cites this paper
• How little we know: the search for a simple answer on acute beta-blocker use in the management of acute coronary syndrome.

  2010cites this paper
• CHAPTER 20 – Ventricular and Supraventricular Arrhythmias in Acute Myocardial Infarction

  2010cites this paper
• [Studies of the outcome of the treatment with beta-blockers in secondary prevention of the ischemic heart disease].

  2009cites this paper
• β-Blocking Agents

  2009cites this paper
• Effect of early treatment with anti-hypertensive drugs on short and long-term mortality in patients with an acute cardiovascular event.

  2009cites this paper
• Role of drug therapy for sustained ventricular tachyarrhythmias.

  2008cites this paper
• Do beta-blockers reduce short-term mortality following acute myocardial infarction? A systematic review and meta-analysis.

  2008cites this paper
• [New data on time factors in the development of myocardial infarction].

  2008cites this paper
• Do β-blockers reduce short-term mortality following acute myocardial infarction? A systematic review and meta-analysis

  2008cites this paper
• [Beta receptor blockers in coronary insufficiency and acute infarct. Pathophysiological bases].

  2008cites this paper
• Evidence-Based Medical Therapy of Patients with Acute Coronary Syndromes

  2007cites this paper
• Early Metoprolol Administration Before Coronary Reperfusion Results in Increased Myocardial Salvage: Analysis of Ischemic Myocardium at Risk Using Cardiac Magnetic Resonance

  2007cites this paper
• Las nuevas evidencias demuestran que no existe indicación para el uso de betabloqueantes intravenosos en el IAM con supradesnivel del ST

  2006cites this paper
• Are lipophilic beta-blockers preferable for peri-operative cardioprotection?:

  2006cites this paper
• PREVENTION / 3-ADRENERGIC BLOCKADE Effect of propranolol after acute myocardial infarction in patients with congestive heart failure

  2005cites this paper
• Outcomes after ventricular fibrillation out-of-hospital cardiac arrest: expanding the chain of survival.

  2005cites this paper
• patients with acute chest pain . the frequency of hypokalaemia in Pre-treatment with beta blockers and

  2005cites this paper
• Effect of adrenaline on myocardial oxygen consumption during selective and non-selective beta-adrenoceptor blockade comparison of atenolol and pindolol

  2004cites this paper
• Effect of adrenaline on myocardial oxygen consumption during selective and non-selective beta-adrenoceptor blockade comparison of atenolol and pindolol

  2004cites this paper
• Differences in haemodynamic response to beta-blocking drugs between stable coronary artery disease and acute myocardial infarction

  2004cites this paper
• The epidemiology of high-risk coronary artery disease and the choice between stents and surgery

  2004cites this paper
• Cardiac protection during acute myocardial infarction: where do we stand in 2004?

  2004cites this paper
• [Beta-blocker in secondary prevention of cardiovascular disease].

  2003cites this paper
• Myokardinfarkt und Beta-Blocker

  2003influential citation
• Existe la insuficiencia cardiaca diastólica

  2003cites this paper
• b-Blocker in der Sekundärprävention von Herz-Kreislauf-Erkrankungen

  2003influential citation
• n-3 fatty acids and the risk of sudden cardiac death. Emphasis on heart rate variability.

  2003cites this paper
• Cardiac Arrhythmias During Acute Myocardial Infarction

  2002cites this paper
• Prevention of and Medical Therapy for Atrial Arrhythmias in Heart Failure

  2002cites this paper
• Optimal treatment and current situation in reperfusion after thrombolysis for acute myocardial infarction

  2002cites this paper
• [Beta blockers in post-infarction state].

  2002cites this paper
• Non-Antithrombotic Treatment of Acute Coronary Syndromes: Role of Beta-Blockers, Calcium Channel Blockers, and Nitrates

  2002cites this paper
• Tachykarde und bradykarde Rhythmusstörungen beim akuten Myokardinfarkt

  2002cites this paper
• Can n-3 fatty acids provide myocardial protection by decreasing infarct size and inhibiting atherothrombosis?

  2001cites this paper
• Tratamiento de la insuficiencia cardíaca. Medidas preventivas. Factores de riesgo asociados

  2001cites this paper
• Incidence, predictive factors, and prognostic significance of supraventricular tachyarrhythmias in congestive heart failure.

  2000cites this paper
• EFFECTS OF A COMBINATION OF BETA CAROTENE AND VITAMIN A ON LUNG CANCER AND CARDIOVASCULAR DISEASE

  2000cites this paper
• Medical Treatment of Coronary Artery Disease

  2000cites this paper
• Challenges in the conduct and interpretation of phase II (pilot) randomized trials.

  2000cites this paper
• How to use ACE-inhibitors, β-blockers, and newer therapies in AMI

  1999cites this paper
• Treatment with beta-blockers for the primary prevention of the cardiovascular complications of hypertension.

  1999cites this paper
• How to use ACE-inhibitors, beta-blockers, and newer therapies in AMI.

  1999cites this paper
• Sudden cardiac death.

  1999cites this paper
• Carvedilol prevents remodeling in patients with left ventricular dysfunction after acute myocardial infarction.

  1999cites this paper
• β-Adrenergic Blockers, Calcium Channel Blockers, and Nitrates

  1999cites this paper
• Importance of beta blockade in the therapy of serious ventricular arrhythmias.

  1998cites this paper
• Chemoprevention of lung cancer: the rise and demise of beta-carotene.

  1998cites this paper
• Health outcomes associated with beta-blocker and diltiazem treatment of unstable angina.

  1998cites this paper
• Medikamentöse Therapie der chronischen Myokardischämie bei koronarer Herzkrankheit

  1998cites this paper
• β-Blocking Agents in Patients with Coronary Artery Disease and Myocardial Infarction

  1998cites this paper
• Adjunctive therapy after reperfusion therapy in acute myocardial infarction

  1998cites this paper
• β-Blocking Therapy in Patients with Unstable Angina

  1998cites this paper
• β-Blocker-Therapie bei akutem Myokardinfarkt

  1997cites this paper
• Increased survival with beta-blockers: importance of ancillary properties.

  1997cites this paper
• Professor Peter Sleight's reflections on the use of beta-blocking agents after myocardial infarction.

  1997cites this paper
• ß-Blocker in der stabilen und instabilen koronaren Herzerkrankung

  1997cites this paper
• Plötzlicher Herztod und lebensbedrohliche ventrikuläre Tachyarrhythmien. Konventionelle β-Blocker im Vergleich zu Sotalol

  1997cites this paper
• [Multi-drug management after myocardial infarct].

  1997cites this paper